Clinical Trial Update: Biomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion Therapy

View source ↗

Summary

A clinical study sponsored by Shanghai Zhongshan Hospital evaluating biomarkers and the molecular mechanisms of hepatocellular carcinoma after radical resection…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Hepatocellular Carcinoma | Status: RECRUITING